Checkpoint Therapeutics (CKPT ) Tops Q3 EPS by 46c

Checkpoint Therapeutics (NASDAQ: CKPT ) reported Q3 EPS of ($0.29), $0.46 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Checkpoint Therapeutics (CKPT ) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Endava CFO placed on leave amid accounting probe
• Evercore lifts Ciena rating on AI-driven optical networking boom